Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
dorsaVi Limited ( (AU:DVL) ) just unveiled an update.
dorsaVi Limited has issued 2,342,009 fully paid ordinary shares under provisions of the Corporations Act that allow share issuance without a disclosure document, and has lodged a cleansing notice confirming compliance with its continuous disclosure and financial reporting obligations. The company also stated that, as at the date of the notice, it is not aware of any excluded information that would need to be disclosed, a step that helps maintain secondary trading liquidity for the new shares and signals adherence to governance and regulatory requirements for existing and prospective shareholders.
The most recent analyst rating on (AU:DVL) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
dorsaVi Ltd (ASX:DVL) is an Australian technology company specialising in innovative motion analysis devices and wearable sensor technology used across clinical applications, elite sports, and occupational health and safety. Its systems capture and quantify detailed human movement and posture outside traditional biomechanics laboratories, providing real-time data for up to 24 hours. The company targets two major markets: workplace risk management—working directly with large corporates and via insurers to reduce injury and compensation claims—and clinical settings, including physiotherapy, hospital-in-the-home, and elite sports performance and return-to-play management.
Average Trading Volume: 4,899,965
Technical Sentiment Signal: Hold
Current Market Cap: A$33.76M
For detailed information about DVL stock, go to TipRanks’ Stock Analysis page.